Preetanshu (Preet) Pandey, Ph.D.

Preet is a pharmaceutical executive with nearly 20 years of experience in drug development, specializing in CMC (Chemistry, Manufacturing, and Controls), global regulatory CMC submissions, and clinical supply chain management.

Prior to joining Boundless Bio, Preet held positions of increasing responsibility at Kura Oncology and Kinnate Biopharma. Earlier in his career, he spent over 12 years at Bristol-Myers Squibb and Merck, where he contributed to the development and commercialization of late-stage drug products. Preet has authored over 40 peer-reviewed publications and book chapters and is a co-inventor of several patent applications.

Preet has a Ph.D. in Chemical Engineering from West Virginia University with a concentration in Pharmaceutical Technology.